Bristol-Myers Squibb International Corporation - NY New York, New York City 10154

Bristol-Myers Squibb International Corporation entered the industry of Biotherapeutics in 1936 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 424210, which describes it as a Biotherapeutics. For further clarification, the SIC classifies this business under the code 5122 and described it as a Biotherapeutics. The business provides service to the BOTH market.

To acquire more information, please contact Peter R Dolan by calling (212) 546-4000 during business hours. You can also write to the business’ Headquarters at 345 Park Avenue, New York City, New York NY 10154. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Bristol-Myers Squibb International Corporation
Representative: Peter R Dolan
Place of Business: 345 Park Avenue, New York City, NY 10154
Contact Number: (212) 546-4000
Type of Service: Biotherapeutics
SIC Number: 5122
NAICS Number: 424210
Locality: Headquarters
Market Type: B2B & B2C
Began: 1936
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Bristol-Myers Squibb International Corporation is a company operating from New York, New York providing professional Biotherapeutics and relevant BOTH variables. It was founded in 1936 and registered with the SIC code 5122 as Biotherapeutics, and with the NAICS code 424210 as Biotherapeutics.

With a current employee count of 1 to 4, Bristol-Myers Squibb International Corporation has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Peter R Dolan at (212) 546-4000 for related queries, or to locate its Headquarters using the coordinates 40.757979,-73.973062.

The Headquarters can also be found at the street address 345 Park Avenue in New York City, New York 10154 and can be engaged online through the company website at , the company Twitter , and Facebook page .